We are live on ! Find out more
SER icon

Serina Therapeutics
SER

48 hedge funds and large institutions have $4.88M invested in Serina Therapeutics in 2020 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 16 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.09% less ownership

Funds ownership: 0.48% → 0.39% (-0.09%)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

2% less funds holding

Funds holding: 49 → 48 (-1)

17% less capital invested

Capital invested by funds: $5.9M → $4.88M (-$1.02M)

75% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 16

Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
0.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
14
Increased
4
Reduced
16
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$201K
2
BCM
Bridgeway Capital Management
Texas
+$130K
3
Bank of America
Bank of America
North Carolina
+$126K
4
OMC
Old Mission Capital
Illinois
+$43.7K
5
PP
Paloma Partners
Connecticut
+$42.7K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$830K
2
State Street
State Street
Massachusetts
-$273K
3
Northern Trust
Northern Trust
Illinois
-$151K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$89.2K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$69.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$11K -$3.44K -117 -27%
ISB
27
Iowa State Bank
Iowa
$10K – – –
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$7K -$795 -27 -11%
UBS Group
29
UBS Group
Switzerland
$7K -$5.83K -198 -48%
TRCT
30
Tower Research Capital (TRC)
New York
$7K +$5.12K +174 +405%
Osaic Holdings
31
Osaic Holdings
Arizona
$3K – – –
PCM
32
Prelude Capital Management
New York
$3K +$3.06K +104 New
BDS
33
Banco de Sabadell
Florida
$2K – – –
Deutsche Bank
34
Deutsche Bank
Germany
$1K -$4.95K -168 -84%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$1K -$648 -22 -35%
RAM
36
Riggs Asset Management
Pennsylvania
$1K – – –
RE
37
RBC Europe
United Kingdom
$540 – – –
State Street
38
State Street
Massachusetts
– -$273K -8,356 Closed
N
39
Nuveen
North Carolina
– -$57K -1,741 Closed
Bank of New York Mellon
40
Bank of New York Mellon
New York
– -$57K -1,739 Closed
Wells Fargo
41
Wells Fargo
California
– -$36.6K -1,242 -98%
JP Morgan Chase
42
JP Morgan Chase
New York
– -$28.9K -981 -99%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
– -$31K -942 Closed
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
– -$20K -606 Closed
VOYA Investment Management
45
VOYA Investment Management
Georgia
– -$17K -513 Closed
Goldman Sachs
46
Goldman Sachs
New York
– -$13K -393 Closed
AIG
47
American International Group
New York
– -$12K -366 Closed
Victory Capital Management
48
Victory Capital Management
Texas
– -$6K -208 Closed
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
– -$6K -198 Closed
Citigroup
50
Citigroup
New York
– -$5.09K -173 -99%
1
2
3

SER Hedge Fund Activity: Q2 2020 in Review

48 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q2 2020, worth a combined $4.88M — down 17% from $5.9M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SER and 14 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 4 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $201K. The largest seller was BlackRock, cutting an estimated $830K.

  • 48 institutional investors held Serina Therapeutics (SER) as of Q2 2020, down from 49 in Q1 2020.
  • Funds reported $4.88M of Serina Therapeutics stock for Q2 2020, down 17% quarter-over-quarter.
  • 14 funds opened new Serina Therapeutics positions in Q2 2020 and 15 closed out, a net change of -1 holder.
  • The largest Serina Therapeutics buyer in Q2 2020 was Millennium Management, an estimated $201K added.
  • The largest Serina Therapeutics seller in Q2 2020 was BlackRock, an estimated $830K sold.

Based on aggregated 13F filings for Q2 2020.